Global COVID Shot Totals and Latest Figures
As of the newest available public data, more than 13 billion COVID vaccine doses have been administered worldwide, according to Our World in Data. This total includes all booster and primary series injections across countries and territories, reflecting the scale of the global immunization campaign. The figure is compiled from national health ministries and international organizations and is updated frequently as new reports are released.
In terms of doses per hundred people, countries such as Portugal, South Korea, and Japan rank among the highest, while many low-income regions still lag behind due to supply and access constraints. The global average sits around 170 doses per hundred people, which exceeds the total population in many places because of booster campaigns. These rankings highlight the uneven distribution of shots across different income groups and regions.
Key Companies and Vaccine Platforms Behind the Doses
Major manufacturers such as Pfizer-BioNTech, Moderna, AstraZeneca, Johnson & Johnson, Sinovac, and Sinopharm have supplied billions of doses to governments worldwide. Pfizer and BioNTech together produced a large share of the mRNA shots used in high-income countries, while Sinovac and Sinopharm delivered significant volumes to developing markets. These companies have reported their production figures in quarterly earnings releases and public health agreements.
Regulatory bodies such as the U.S. Food and Drug Administration, the European Medicines Agency, and the World Health Organization have evaluated and authorized these vaccines under various pathways, including emergency use listings. The speed of authorization and manufacturing scale has shaped how quickly shots rolled out in different countries. For a detailed timeline of authorizations and production, see the overview provided by the FDA COVID-19 Vaccines page.
How the Doses Are Counted and Reported
Dose Definitions and Administration Methods
Health authorities define a single dose as one injection given to one individual, and a full primary series typically includes two doses for mRNA vaccines or one dose for the Johnson & Johnson vaccine. Booster doses are counted separately in many reporting systems, which can make global totals appear higher than the number of unique individuals vaccinated. Most doses are administered intramuscularly, with a small share given intradermally in some pilot programs.
Data Sources and Reporting Gaps
Aggregators such as Our World in Data and the Bloomberg Vaccine Tracker compile national reports from ministries of health, but coverage can be incomplete in regions with weak health infrastructure. Some countries report only partial data or update their figures irregularly, leading to gaps in the global picture. Despite these challenges, the overall trend shows a steady increase in total shots administered over the course of the pandemic.
Why Accurate Counts Matter for Finance and Policy
Accurate dose counts inform government spending on procurement, distribution logistics, and booster campaign planning. Investors and analysts track vaccine production and distribution as part of the broader healthcare and biotechnology sectors, as supply contracts and market access depend on transparent reporting. The SEC filings of major pharmaceutical companies also provide insight into revenue and volume commitments tied to these doses.
Looking Ahead
Future updates to global shot totals will depend on continued data sharing, booster recommendations, and the emergence of new variants that may require additional doses. The current cumulative figure remains the most comprehensive public measure of the scale of COVID vaccination efforts worldwide.